Skip to content
2000
Volume 28, Issue 37
  • ISSN: 0929-8673
  • E-ISSN: 1875-533X

Abstract

Striatal-enriched protein tyrosine phosphatase (STEP) is exclusively expressed in the central nervous system and regulates various neuronal signaling factors through the dephosphorylation of different substrates. Dysregulated expression or uncontrollable enzymatic activity of STEP contributes to neurological disorders such as Alzheimer's disease, which makes it a promising pharmaceutical target. Herein, we have reviewed the structure and biological functions of STEP, as well as the recent development of smallmolecule STEP modulators. We hope this review will provide a reference for the further development of more potent and selective STEP inhibitors for the treatment of nervous system diseases.

Loading

Article metrics loading...

/content/journals/cmc/10.2174/0929867328666210412123304
2021-11-01
2025-07-03
Loading full text...

Full text loading...

/content/journals/cmc/10.2174/0929867328666210412123304
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test